CVS Health (CVS) Tops Q3 EPS by 7c; Trims, Narrows FY16 EPS Outlook

CVS Health (CVS) Model Not Broken, Buy on Weakness - Guggenheim

Guggenheim analyst John Heinbockel said at flat 2017 at CVS Health (NYSE: CVS) doesn't mean the model is broken. He said patient, value investors should find the shares compelling..

Heinbocke commented, "With the shares off 15% pre-market (vs. 2% decline in the S&P), a... More

Mizuho Recommends Buying CVS (CVS) on Today's Weakness, Driven by Retail

Mizuho Securities analyst Ann Hynes weighed in on CVS Health (NYSE: CVS) after the company post rare guidance reduction on retail weakness.

Hynes commented, "CVS reported a 3Q beat (adjusted EPS of $1.64 versus consensus $1.57E), but lowered 2016E guidance by 1% at the midpoint. 2017E initial guidance was provided early (usually given in December) and its 10% below our and Street estimates at the mid-point. CVS also provided an updated on its long-term guidance at +10%, which is below current of +10-14% but in-line (or better) than Street expectations given the lack of generic introduction... More

CVS Health (CVS) Q3 Solid But Guidance Well Behind - Leerink

Leerink Partners analyst David Larsen weighed in on CVS Health (NYSE: CVS) following solid Q3 results but disappointing guidance which has the stock down 15.3%.

Larsen commented, "This morning CVS reported 3Q:16 earnings. While earnings in the quarter were solid, guidance was disappointing.... More

Walgreens Boots Alliance (WBA) Trades Lower in Sympathy with CVS Health (CVS)

Walgreens Boots Alliance (NASDAQ: WBA) was poised to open lower Tuesday morning as shares fell in sympathy with CVS Health (NYSE: CVS).

CVS declined 16% after reporting Q3 results and guidance that disappointed investors.

Stocks with Implied Volatility Movement

CVS Health (NYSE: CVS) implied volatility at upper end of index mean range